XML 115 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Reporting and Foreign Operations (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Long-lived Assets by Geographic Area

Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2023, 2022 and 2021, consisted of the following (in thousands):

    

2023

    

2022

    

2021

United States

$

273,105

$

281,290

$

275,311

Ireland

 

42,333

 

40,749

 

39,863

Other foreign countries

 

68,085

 

60,937

 

56,484

Total

$

383,523

$

382,976

$

371,658

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2023, 2022 and 2021, are as follows (in thousands):

2023

    

2022

    

2021

Net sales

  

 

  

 

  

Cardiovascular

$

1,220,560

$

1,118,224

$

1,043,227

Endoscopy

 

36,806

 

32,757

 

31,524

Total net sales

 

1,257,366

 

1,150,981

 

1,074,751

Income from operations

 

  

 

  

 

  

Cardiovascular

 

114,440

 

80,946

 

53,415

Endoscopy

 

9,504

 

6,617

 

7,501

Total income from operations

 

123,944

 

87,563

 

60,916

Total other expense — net

 

(11,855)

 

(4,934)

 

(6,999)

Income tax expense

 

17,678

 

8,113

 

5,463

Net income

$

94,411

$

74,516

$

48,454

Total depreciation and amortization by operating segment for the years ended December 31, 2023, 2022 and 2021, consisted of the following (in thousands):

    

2023

    

2022

    

2021

Cardiovascular

$

88,960

$

80,777

$

83,000

Endoscopy

 

1,025

 

1,027

 

1,066

Total

$

89,985

$

81,804

$

84,066

Total capital expenditures for property and equipment by operating segment for the years ended December 31, 2023, 2022 and 2021, consisted of the following (in thousands):

    

2023

    

2022

    

2021

Cardiovascular

$

33,985

$

44,925

$

27,557

Endoscopy

 

305

 

104

 

382

Total

$

34,290

$

45,029

$

27,939

Reconciliation of Assets from Segment to Consolidated

2023

    

2022

    

2021

Net sales

  

 

  

 

  

Cardiovascular

$

1,220,560

$

1,118,224

$

1,043,227

Endoscopy

 

36,806

 

32,757

 

31,524

Total net sales

 

1,257,366

 

1,150,981

 

1,074,751

Income from operations

 

  

 

  

 

  

Cardiovascular

 

114,440

 

80,946

 

53,415

Endoscopy

 

9,504

 

6,617

 

7,501

Total income from operations

 

123,944

 

87,563

 

60,916

Total other expense — net

 

(11,855)

 

(4,934)

 

(6,999)

Income tax expense

 

17,678

 

8,113

 

5,463

Net income

$

94,411

$

74,516

$

48,454